MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202611113098 A) filed by Rupa Mazumder; Mr. Chittathur Midhun Krishna; Dr. Rakhi Mishra; Dr. Anjna Rani; Ms Pakhi Chakraborty; Ms. Madhurima; Ms Arpita Dua; and Mrs. Shruti Varshney on September 21, 2026, for Baicalin-Loaded Brain Targeted Prussian Blue Nanoparticles Formulation Against Glioblastoma And A Process For Preparing Thereof.
Inventors include Rupa Mazumder; Mr. Chittathur Midhun Krishna; Dr. Rakhi Mishra; Dr. Anjna Rani; Ms Pakhi Chakraborty; Ms. Madhurima; Ms Arpita Dua; and Mrs. Shruti Varshney.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: The present invention discloses a process for preparing baicalin-loaded brain targeted prussian blue nanoparticles against glioblastoma, said process comprising of preparing prussian blue nanoparticle solution by using citric acid monohydrate, ferric chloride hexahydrate and Potassium hexacyanoferrate solution; dissolving a predefined quantity of baicalin in 5 mL of 30% methanol to form a drug solution; adding the drug solution to the prussian blue nanoparticle solution in a predefined ratio to form baicalin-loaded brain targeted prussian blue nanoparticles; incubating the baicalin-loaded brain targeted prussian blue nanoparticles on mild shaking for a predefined period of time; and centrifuging the baicalin-loaded brain targeted prussian blue nanoparticles to remove excess drug solution.
Disclaimer: Curated by HT Syndication.
